By the Numbers
Turning your generosity into treatments for children
Every 80 seconds, a child is diagnosed with cancer.
Scientific progress is creating new possibilities every day, but those discoveries only matter if they reach the children who need them.
That is where CureSearch comes in.
More than numbers
Investing in people.
Advancing the science.
Reaching patients.
Our impact is measured not only in dollars invested, but in what those dollars set in motion: talented researchers backed, promising science advanced, new treatment approaches moved closer to children, and the early evidence scientists need to unlock larger federal investments.
That is the power of a CureSearch investment. We fund at the moment when the right capital can change what happens next, helping promising science prove its potential, attract significantly greater funding, and keep moving toward the children who need it. Our dollars don’t simply fund research. They create momentum.
Strategic investment.
Measurable impact.
We don’t measure success by the number of grants we make. We measure it by what happens after we invest.
- 70% of Young Investigators went on to secure federal funding after receiving a CureSearch award Our early-career investments help launch enduring research careers and attract significantly larger sources of support.
- 71% of preclinical projects far enough along to assess have advanced to clinical trials The majority of our preclinical investments move forward, a success rate more than twice the typical rate for new cancer therapies.
- 2X+ the typical success rate for advancing new cancer therapies from preclinical research to clinical trials Our process is designed to identify and move the most promising science forward.
- 20+Pediatric cancer types studied by CureSearch-funded researchers.
- 9,000+Children each year are diagnosed with cancers targeted by CureSearch-funded clinical trials.
Research with reach
Promising science can come
from anywhere.
So we go where the strongest science leads us.
CureSearch evaluates research through a rigorous, objective review process designed to identify the projects with the greatest potential to become new treatments for children. Our funding decisions aren’t driven by geography, institutional reputation, or anything other than the strength and potential of the science.
We fund the best science with the greatest potential to become a treatment for a child. Wherever we find it.
See all research awards as a list, with links to each project
Aurora, Colorado
University of Colorado
Children’s Hospital Colorado
Boston, Massachusetts
Dana-Farber Cancer Institute
- Lynda Vrooman, MD
- Andrew Lee Hong, MD
- Birgit Knoechel, MD, PhD
- Loretta Li, MD
- Adam Durbin, MD, PhD
- Robbie Majzner, MD
Massachusetts General Hospital
Houston, Texas
Baylor College of Medicine
Texas Children’s Hospital
MD Anderson Cancer Center
Los Angeles, California
University of California, Los Angeles
Children’s Hospital Los Angeles
New Haven, Connecticut
Yale University
New York, New York
Memorial Sloan Kettering Cancer Center
Icahn School of Medicine at Mount Sinai
Philadelphia, Pennsylvania
University of Pennsylvania
Children’s Hospital of Philadelphia
People
Young Investigator Awards
Awards of $225,000
Investing in the researchers who will shape what comes next.
Scientific progress depends on talented researchers choosing to build their careers in pediatric cancer. Through our Young Investigator Awards, CureSearch gives promising early-career scientists the funding and support to pursue innovative ideas, establish independent research programs, and remain in the field.
Science
Acceleration Initiative Awards
Awards of up to $1.5 million
Advancing promising discoveries toward the clinic.
A promising discovery is only the beginning. CureSearch’s Acceleration Initiative funds the rigorous preclinical work needed to determine whether a new treatment approach is ready to move into clinical testing.
Patients
Catapult Awards
Awards of up to $2.5 million
Bringing new treatment approaches into clinical testing.
Clinical trials are the point where years of laboratory research begin to be evaluated in patients. Through our Catapult Awards, CureSearch funds early-phase pediatric cancer trials that test the safety, dosing, and early promise of new treatment approaches for children and young adults.
A researcher’s perspective
“I can think of no other foundation primarily focused in funding the developmental work necessary to bring forward new discoveries into groundbreaking clinical trials for the heroic children battling cancer.”
The next breakthrough starts here
Help make the next investment possible.
Progress happens one researcher, one discovery, and one clinical trial at a time. Your support helps make the next investment possible and brings better treatments closer to children with cancer.
